Product Name:

NebuSelect™ Recombinant Human AGER, His-tag

Catalog#:

NBL-243126

Description:

NebuSelect™ Recombinant Human AGER, His-tag(Cat#NBL-243126) is expressed in HEK293 with His tag at the C-Terminus.It contains Ala23- Ala344.

Species:

Human

Expression System:

HEK293

Molecular Weight: 

The protein has a predicted MW of 35.3 kDa. Due to glycosylation, the protein migrates to 50-60 kDa based on Bis-Tris PAGE result.

Target Name:

AGER; AGER; RAGE; SCARJ1

Target Information:

The receptor for advanced glycation end products (AGER) is an oncogenic transmembranous receptor up-regulated in various human cancers. AGER promotes proliferation, migration, and inhibits apoptosis of squamous cervical cancer and might function as a tumor promoter in cervical cancer. Our study provides novel evidence for a potential role of AGER in bridging human papillomavirus (HPV)-induced inflammation and cervical cancer.

Amino Acid Sequence: 

Ala23- Ala344

Purity:

＞95%

Formulation:

see COA

Endotoxin:

＜1EU/ug(LAL Method)

Storage: 

4°C for short term. 

-20°C for long term.

To get more information, please contact us freely.